Unilife (UNIFF.PK) CEO Video Interview on CNBC |
 |
 |
| Saturday, 28 November 2009 10:03 |
|
The market opportunity for prefilled syringes includes 50 drugs (primary anti-coagulant / hematology medications, vaccines, and other biological agents) that are delivered by injection, including an estimated 3 billion prefilled syringes in use by 2012. Below are some links to articles, reports, and presentations for Unilife, with more information available at the Company's ProActive News Room landing page, including the CNBC video since the video embed code is not displaying correctly in this article. Seeking Alpha Articles / Mike Havrilla Unilife Medical (OTC: UNIFF.PK): Griffin Securities 8/19/09 Unilife Medical (OTC: UNIFF.PK): Sept. 2009 Presentation Unilife Medical (OTC: UNIFF.PK): CCZ Equities 10/13/09 Unilife Medical (OTC: UNIFF.PK): Annual Report 10/30/09 More than two billion prefilled syringes are currently used each year on a global basis and pharmaceutical companies are making the switch to products such as Unilife's safety syringe which are compliant with needle-stick prevention laws (e.g. Federal Needlestick Prevention Act, 2000). Key differentiating features of Unilife's fully-integrated (within the barrel of the syringe) safety syringes include the following: 1.) a passive needle retraction system that is activated inside the body 2.) healthcare providers / shot administrators control the speed of needle retraction 3.) auto-disabling prevents re-use or tampering with used syringes. Disclosure: No positions.
BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section Add this page to your favorite Social Bookmarking websites            |
Unilife Medical Solutions
Free Phone Trade Alerts
